SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-320360
Filing Date
2013-08-06
Accepted
2013-08-06 08:01:52
Documents
3
Period of Report
2013-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d580603d8k.htm 8-K 14535
2 EX-99.1 d580603dex991.htm EX-99.1 210693
3 GRAPHIC g580603g88f20.jpg GRAPHIC 27259
  Complete submission text file 0001193125-13-320360.txt   264228
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35144 | Film No.: 131011875
SIC: 2834 Pharmaceutical Preparations